| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,994 |
7,962 |
$777K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,966 |
4,196 |
$538K |
| 99442 |
|
1,467 |
1,125 |
$110K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
514 |
514 |
$82K |
| 83970 |
|
1,841 |
1,829 |
$74K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,971 |
1,957 |
$56K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
429 |
428 |
$48K |
| 86769 |
|
1,359 |
1,349 |
$48K |
| 82670 |
|
1,495 |
1,483 |
$41K |
| 82784 |
|
1,414 |
1,399 |
$37K |
| 82627 |
|
1,498 |
1,485 |
$31K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
1,618 |
1,273 |
$29K |
| 82728 |
|
1,840 |
1,821 |
$23K |
| 82607 |
|
1,856 |
1,834 |
$22K |
| 93000 |
|
1,595 |
1,578 |
$21K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
295 |
273 |
$19K |
| 99401 |
|
1,705 |
1,487 |
$19K |
| 82746 |
|
1,590 |
1,577 |
$18K |
| 80053 |
Comprehensive metabolic panel |
1,964 |
1,938 |
$18K |
| 86141 |
|
1,832 |
1,810 |
$18K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,828 |
1,816 |
$17K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
220 |
195 |
$16K |
| 93880 |
|
115 |
115 |
$16K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,807 |
1,792 |
$16K |
| 82785 |
|
1,336 |
1,324 |
$15K |
| 84439 |
|
1,802 |
1,786 |
$15K |
| 84403 |
|
585 |
579 |
$14K |
| 93975 |
|
71 |
66 |
$14K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
38 |
38 |
$11K |
| 80061 |
Lipid panel |
1,875 |
1,860 |
$11K |
| 84480 |
|
1,798 |
1,782 |
$10K |
| 93922 |
|
153 |
152 |
$10K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
39 |
39 |
$9K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
24 |
24 |
$8K |
| 83540 |
|
1,853 |
1,833 |
$8K |
| 83735 |
|
1,788 |
1,780 |
$8K |
| 86328 |
|
248 |
245 |
$8K |
| 84681 |
|
398 |
398 |
$8K |
| 84100 |
|
1,718 |
1,709 |
$7K |
| 82977 |
|
1,521 |
1,505 |
$7K |
| 84550 |
|
1,743 |
1,730 |
$7K |
| 83615 |
|
1,531 |
1,515 |
$7K |
| 83550 |
|
1,409 |
1,395 |
$7K |
| 86376 |
|
461 |
455 |
$6K |
| 93015 |
|
122 |
121 |
$6K |
| 84402 |
|
243 |
243 |
$6K |
| 84144 |
|
291 |
291 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,691 |
1,657 |
$6K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
709 |
692 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
40 |
40 |
$5K |
| 83001 |
|
284 |
284 |
$5K |
| J2785 |
Injection, regadenoson, 0.1 mg |
37 |
37 |
$5K |
| 83002 |
|
282 |
282 |
$5K |
| 84146 |
|
256 |
256 |
$5K |
| 83525 |
|
444 |
443 |
$5K |
| 93978 |
|
25 |
25 |
$4K |
| 84153 |
|
176 |
174 |
$3K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
582 |
573 |
$3K |
| 86431 |
|
358 |
353 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
44 |
41 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
44 |
37 |
$1K |
| 83721 |
|
1,484 |
1,348 |
$1K |
| 84270 |
|
715 |
712 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
30 |
24 |
$959.60 |
| 0011A |
|
23 |
23 |
$959.56 |
| 95923 |
|
12 |
12 |
$906.80 |
| 71046 |
Radiologic examination, chest; 2 views |
36 |
36 |
$896.42 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
63 |
39 |
$859.52 |
| 0012A |
|
20 |
20 |
$834.97 |
| 96127 |
|
270 |
244 |
$834.82 |
| 81003 |
|
492 |
480 |
$770.13 |
| 36415 |
Collection of venous blood by venipuncture |
3,115 |
2,995 |
$682.01 |
| 0013A |
|
13 |
13 |
$565.54 |
| 86160 |
|
28 |
26 |
$546.00 |
| 95921 |
|
12 |
12 |
$534.80 |
| 81005 |
|
326 |
322 |
$490.04 |
| 81002 |
|
254 |
250 |
$473.47 |
| 82172 |
|
27 |
27 |
$423.34 |
| 3074F |
|
628 |
557 |
$417.50 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
24 |
24 |
$361.21 |
| 94010 |
|
15 |
15 |
$331.22 |
| 3078F |
|
505 |
446 |
$325.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
40 |
40 |
$231.35 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
12 |
12 |
$220.12 |
| 82962 |
|
441 |
373 |
$175.93 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
2,397 |
2,130 |
$142.01 |
| 36000 |
|
12 |
12 |
$100.00 |
| 3079F |
|
79 |
77 |
$70.00 |
| 99051 |
|
12 |
12 |
$69.30 |
| 3075F |
|
56 |
55 |
$42.50 |
| 83695 |
|
58 |
58 |
$17.18 |
| 82247 |
|
620 |
618 |
$7.82 |
| 3288F |
|
277 |
241 |
$0.00 |
| 4004F |
|
98 |
91 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
84 |
69 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
44 |
35 |
$0.00 |
| 1159F |
|
21 |
19 |
$0.00 |
| 1036F |
|
221 |
194 |
$0.00 |
| 3044F |
|
52 |
43 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
83 |
69 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
17 |
13 |
$0.00 |
| 3061F |
|
14 |
12 |
$0.00 |
| 1126F |
|
13 |
12 |
$0.00 |
| 3008F |
|
23 |
20 |
$0.00 |
| 1170F |
|
14 |
12 |
$0.00 |
| 3017F |
|
16 |
14 |
$0.00 |